TAF1L RNAi

Images

 

Product Details

Summary
Reactivity HuSpecies Glossary
Applications RNAi, RNAi SP

Order Details

TAF1L RNAi Summary

Specificity
TAF1-like RNA polymerase II, TATA box binding protein (TBP)-associated factor, 210kDa (TAF1L), mRNA
Gene
TAF1L

Applications/Dilutions

Application Notes
This RNAi causes protein knockdown.

Packaging, Storage & Formulations

Storage
Store at -20C. Avoid freeze-thaw cycles.

Notes

This product is produced by and distributed for Abnova, a company based in Taiwan.

Alternate Names for TAF1L RNAi

  • 210kDa
  • 210kDa-like
  • EC 2.7.11
  • EC 2.7.11.1
  • MGC134910
  • TAF(II)210
  • TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor
  • TAF1-like RNA polymerase II, TATA box binding protein (TBP)-associated factor
  • TAF2A2
  • TBP-associated factor 1-like
  • TBP-associated factor 210 kDa
  • TBP-associated factor RNA polymerase 1-like
  • Transcription initiation factor TFIID 210 kDa subunit
  • transcription initiation factor TFIID subunit 1-like

Background

Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene.  The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo.  Chimera RNAi has many advantages over the conventional siRNAs.  First, it has been demonstrated to have reliable knock-down for over 10,000 human genes.  Because the human genome is composed of an intricate, genetic network, chimera RNAi's unique design has successfully obviated the off-target effects including microRNA-based influence.  Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected.  Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. RNAi are guaranteed for 3 months from date of receipt.

Customers Who Viewed This Item Also Viewed...

NBP1-77847
Species: Hu, Mu, Rt
Applications: WB, ChIP, ELISA, IHC, IHC-P, IP
AF1334
Species: Hu
Applications: WB, IHC
NBP2-12933
Species: Hu, Mu, Rt, Po
Applications: WB, PEP-ELISA
NBP2-38188
Species: Hu
Applications: WB, ICC/IF, IHC, IHC-P

Publications for TAF1L RNAi (H00138474-R03) (0)

There are no publications for TAF1L RNAi (H00138474-R03).
By submitting your publication information earn gift cards and discounts for future purchases.

Reviews for TAF1L RNAi (H00138474-R03) (0)

There are no reviews for TAF1L RNAi (H00138474-R03). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
  • 1st to review with an image -- $50/€35/£30/$50 CAD/¥300 Yuan/¥5000 Yen

FAQs for TAF1L RNAi (H00138474-R03) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional TAF1L Products

Bioinformatics Tool for TAF1L RNAi (H00138474-R03)

Discover related pathways, diseases and genes to TAF1L RNAi (H00138474-R03). Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
Visit Tool

Pathways for TAF1L RNAi (H00138474-R03)

View related products by pathway.

Research Areas for TAF1L RNAi (H00138474-R03)

Find related products by research area.

Blogs on TAF1L

There are no specific blogs for TAF1L, but you can read our latest blog posts.

Customers Who Bought This Also Bought

TAF1L Antibody (1E12)
H00138474-M01

Contact Information

Product PDFs

Review this Product

Be the first to review our TAF1L RNAi and receive a gift card or discount.

Bioinformatics

Gene Symbol TAF1L